446 related articles for article (PubMed ID: 9091799)
1. Malignant melanoma in patients treated for psoriasis with methoxsalen (psoralen) and ultraviolet A radiation (PUVA). The PUVA Follow-Up Study.
Stern RS; Nichols KT; Väkevä LH
N Engl J Med; 1997 Apr; 336(15):1041-5. PubMed ID: 9091799
[TBL] [Abstract][Full Text] [Related]
2. The risk of melanoma in association with long-term exposure to PUVA.
Stern RS;
J Am Acad Dermatol; 2001 May; 44(5):755-61. PubMed ID: 11312420
[TBL] [Abstract][Full Text] [Related]
3. The risk of squamous cell and basal cell cancer associated with psoralen and ultraviolet A therapy: a 30-year prospective study.
Stern RS;
J Am Acad Dermatol; 2012 Apr; 66(4):553-62. PubMed ID: 22264671
[TBL] [Abstract][Full Text] [Related]
4. Risks of cancer associated with long-term exposure to PUVA in humans: current status--1991.
Stern RS
Blood Cells; 1992; 18(1):91-7; discussion 98-9. PubMed ID: 1617196
[TBL] [Abstract][Full Text] [Related]
5. Incidence of skin cancers in 3867 patients treated with narrow-band ultraviolet B phototherapy.
Hearn RM; Kerr AC; Rahim KF; Ferguson J; Dawe RS
Br J Dermatol; 2008 Sep; 159(4):931-5. PubMed ID: 18834483
[TBL] [Abstract][Full Text] [Related]
6. Outcomes of pregnancies among women and partners of men with a history of exposure to methoxsalen photochemotherapy (PUVA) for the treatment of psoriasis.
Stern RS; Lange R
Arch Dermatol; 1991 Mar; 127(3):347-50. PubMed ID: 1998364
[TBL] [Abstract][Full Text] [Related]
7. Genital tumors among men with psoriasis exposed to psoralens and ultraviolet A radiation (PUVA) and ultraviolet B radiation. The Photochemotherapy Follow-up Study.
Stern RS
N Engl J Med; 1990 Apr; 322(16):1093-7. PubMed ID: 2320078
[TBL] [Abstract][Full Text] [Related]
8. Lymphoma risk in psoriasis: results of the PUVA follow-up study.
Stern RS
Arch Dermatol; 2006 Sep; 142(9):1132-5. PubMed ID: 16983000
[TBL] [Abstract][Full Text] [Related]
9. Risk of skin tumors in psoralen- and ultraviolet A-treated patients.
Henseler T; Christophers E
Natl Cancer Inst Monogr; 1984 Dec; 66():217-9. PubMed ID: 6531033
[TBL] [Abstract][Full Text] [Related]
10. PUVA treatment and skin cancer: A follow-up study.
Lassus A; Reunala T; Idänpää-Heikkilä J; Juvakoski T; Salo O
Acta Derm Venereol; 1981; 61(2):141-5. PubMed ID: 6165190
[TBL] [Abstract][Full Text] [Related]
11. Cutaneous carcinoma and 8-methoxypsoralen and ultraviolet A (PUVA) lentigines in Japanese patients with psoriasis treated with topical PUVA: a follow-up study of 214 patients.
Takashima A; Matsunami E; Yamamoto K; Kitajima S; Mizuno N
Photodermatol Photoimmunol Photomed; 1990 Oct; 7(5):218-21. PubMed ID: 2091746
[TBL] [Abstract][Full Text] [Related]
12. Carcinogenic risks of psoralen UV-A therapy and narrowband UV-B therapy in chronic plaque psoriasis: a systematic literature review.
Archier E; Devaux S; Castela E; Gallini A; Aubin F; Le Maître M; Aractingi S; Bachelez H; Cribier B; Joly P; Jullien D; Misery L; Paul C; Ortonne JP; Richard MA
J Eur Acad Dermatol Venereol; 2012 May; 26 Suppl 3():22-31. PubMed ID: 22512677
[TBL] [Abstract][Full Text] [Related]
13. Psoralen plus ultraviolet A does not increase the risk of cataracts: a 25-year prospective study.
Malanos D; Stern RS
J Am Acad Dermatol; 2007 Aug; 57(2):231-7. PubMed ID: 17532094
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous squamous-cell carcinoma in patients treated with PUVA.
Stern RS; Laird N; Melski J; Parrish JA; Fitzpatrick TB; Bleich HL
N Engl J Med; 1984 May; 310(18):1156-61. PubMed ID: 6709010
[TBL] [Abstract][Full Text] [Related]
15. Long-term photochemotherapy for psoriasis: a histopathological and clinical follow-up study with special emphasis on tumour incidence and behavior of pigmented lesions.
Ros AM; Wennersten G; Lagerholm B
Acta Derm Venereol; 1983; 63(3):215-21. PubMed ID: 6192634
[TBL] [Abstract][Full Text] [Related]
16. [Photochemotherapy--psoralen + UV-A (PUVA)--increased risk of cancer?].
Harnes DK; Thune P
Tidsskr Nor Laegeforen; 1993 Jan; 113(2):200-1. PubMed ID: 8430401
[TBL] [Abstract][Full Text] [Related]
17. Malignant melanoma and other second cutaneous malignancies in cutaneous T-cell lymphoma. The influence of additional therapy after total skin electron beam radiation.
Licata AG; Wilson LD; Braverman IM; Feldman AM; Kacinski BM
Arch Dermatol; 1995 Apr; 131(4):432-5. PubMed ID: 7726585
[TBL] [Abstract][Full Text] [Related]
18. Antinuclear antibodies and oral methoxsalen photochemotherapy (PUVA) for psoriasis.
Stern RS; Morison WL; Thibodeau LA; Kleinerman RA; Parrish JA; Geer DE; Fitzpatrick TB
Arch Dermatol; 1979 Nov; 115(11):1320-4. PubMed ID: 389166
[TBL] [Abstract][Full Text] [Related]
19. Risk of cutaneous carcinoma in patients treated with oral methoxsalen photochemotherapy for psoriasis.
Stern RS; Thibodeau LA; Kleinerman RA; Parrish JA; Fitzpatrick TB
N Engl J Med; 1979 Apr; 300(15):809-13. PubMed ID: 423919
[TBL] [Abstract][Full Text] [Related]
20. Randomized, double-blind comparison of 1 mg/L versus 5 mg/L methoxsalen bath-PUVA therapy for chronic plaque-type psoriasis.
Vongthongsri R; Konschitzky R; Seeber A; Treitl C; Hönigsmann H; Tanew A
J Am Acad Dermatol; 2006 Oct; 55(4):627-31. PubMed ID: 17010742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
